SQZ BIOTECHNOLOGIES COMPANY Increase (Decrease) in Accounts Receivable
SQZ BIOTECHNOLOGIES COMPANY reported Increase (Decrease) in Accounts Receivable of -$3.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2023-11-08
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for the quarter ending 2022-09-30 was $0.00.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was $0.00.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was -$3.00M.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for fiscal 2022 was -$3.00M, a 370.76% decline from fiscal 2021.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for fiscal 2021 was $1.11M, a 6055.56% increase from fiscal 2020.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for fiscal 2020 was $18.00K, a 98.22% decline from fiscal 2019.
- SQZ BIOTECHNOLOGIES COMPANY increase (decrease) in accounts receivable for fiscal 2019 was $1.01M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 derived: sum of 3 quarters · filed 2023-11-08 | -$3.00M 10-K · filed 2023-03-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | -$3.00M 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$3.00M 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-08-10 | $0.00 derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$3.00M 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | $0.00 derived: sum of 3 quarters · filed 2023-05-10 | $0.00 derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.00M derived: sum of 2 quarters · filed 2023-03-22 | $3.00M derived: sum of 3 quarters · filed 2023-03-22 | $1.11M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | -$1.89M 10-Q · filed 2022-11-09 | -$1.86M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.89M 10-Q · filed 2022-08-04 | -$1.86M derived: sum of 3 quarters · filed 2022-08-04 | -$1.84M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | -$1.89M 10-Q · filed 2022-05-10 | -$1.86M derived: sum of 2 quarters · filed 2022-05-10 | -$1.84M derived: sum of 3 quarters · filed 2022-05-10 | -$2.63M derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $54.00K derived: sum of 2 quarters · filed 2022-03-16 | -$741.00K derived: sum of 3 quarters · filed 2022-03-16 | $18.00K 10-K · filed 2022-03-16 | |
| 2020-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$777.00K derived: sum of 2 quarters · filed 2021-11-10 | -$18.00K 10-Q · filed 2021-11-10 | $18.00K 10-Q · filed 2020-12-10 | -$621.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$795.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$36.00K 10-Q · filed 2021-08-04 | -$639.00K derived: sum of 3 quarters · filed 2021-08-04 | ||
| 2020-03-31 | $759.00K 10-Q · filed 2021-05-11 | $156.00K derived: sum of 2 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.01M 10-K · filed 2021-03-18 | |||
| 2019-09-30 | $1.61M 10-Q · filed 2020-12-10 |